What is Adiponectin Testing Market?
Adiponectin plays a very important role in the pathogenesis of dyslipidemia. The presence of adiponectin affects HDL and LDL metabolism. Adiponectin is adipose tissue, a derived hormone with a feedback signal function. It is used to regulate the metabolism of the energy substrate and also body composition. It is a protein found in abundance in serum adipokine and excreted by adipose tissue. Adiponectin has shown significant clinical potential as an adipocyte-derived protein in the pathophysiology of metabolic and coronary arteries. Higher levels of circulating adiponectin are associated with a high risk of adverse cardiovascular events, pre-diabetes, and metabolic syndrome. Several studies conducted on animal models have highlighted these results, an important evolutionary factor for the adiponectin testing market. The healthcare industry has also focused on the form that will benefit from animal testing that utilizes the hormone's anti-inflammatory, antiatherogenic, cardiomyocyte protective, and insulin-sensitizing properties.
The market study is being classified by Type (ELISA Testing, Enzyme Immunoassay Testing and Others), by Application (Hospital, Specialty Clinic, Diagnostics Laboratory and Others) and major geographies with country level break-up.
Eagle Biosciences (United States), Stratec Biomedical Systems (Germany), Boster Biological Technology (United States), Merck & Co. (United States), Thermo Fisher Scientific (United States), Bio-Rad Laboratories (United States) and LabCorp (United States) are some of the key players profiled in the study.
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Adiponectin Testing market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Adiponectin Testing market by Type, Application and Region.
On the basis of geography, the market of Adiponectin Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- The Growing Demand for Population for the Diagnosis of Hypoadiponectinemia
- Growing Epidemic of Obese Population of All Ages
- Increasing Number of Research Laboratories and Diagnostic Laboratories
- The Advent of Functional Food Ingredients That Claim To Improve Adipocyte Health and Adiponectin Metabolism
- Increasing Number of Hospitals, Increasing Healthcare Expenditure and Increasing Disposable Income
- Increasing Healthcare Awareness, Among the People
- High Cost of Adiponectin Test
- Advances in Laboratory Infrastructure for Adiponectin Tests
- Manufacturers of Testing Kits in Adiponectin Testing Market Are Striving To Expand the Product Portfolio
- Lack of Awareness in Some of the Developing Regions
- Poor Availability of Medical Facilities
Key Target AudienceProviders of Adiponectin Testing, Research Institute, Potential Investors, Hospitals Sectors and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase